Mirador Therapeutics
Maulik S. has a background in finance and healthcare, with experience ranging from internships at various companies to roles as an Analyst and Vice President of Strategy. Their expertise lies in healthcare, long/short equity, biotech, pharma, medical devices, and the pharma supply chain. Maulik holds a Bachelor of Science degree in Finance and Accounting from The Wharton School.
This person is not in any offices
Mirador Therapeutics
Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly advance new precision medicines for patients living with chronic immune-mediated inflammatory and fibrotic diseases. Launched in 2024, Mirador has raised over $400 million from leading life sciences investors and is based in San Diego, CA.